BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20804921)

  • 1. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
    Bosco N; Pelliccia F; Rocchi A
    Cancer Genet Cytogenet; 2010 Oct; 202(1):47-52. PubMed ID: 20804921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the human common fragile site FRA1H.
    Curatolo A; Limongi ZM; Pelliccia F; Rocchi A
    Genes Chromosomes Cancer; 2007 May; 46(5):487-93. PubMed ID: 17311248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stably transfected common fragile site sequences exhibit instability at ectopic sites.
    Ragland RL; Glynn MW; Arlt MF; Glover TW
    Genes Chromosomes Cancer; 2008 Oct; 47(10):860-72. PubMed ID: 18615677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors.
    Morelli C; Karayianni E; Magnanini C; Mungall AJ; Thorland E; Negrini M; Smith DI; Barbanti-Brodano G
    Oncogene; 2002 Oct; 21(47):7266-76. PubMed ID: 12370818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
    Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
    Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions.
    Fechter A; Buettel I; Kuehnel E; Savelyeva L; Schwab M
    Genes Chromosomes Cancer; 2007 Jan; 46(1):98-106. PubMed ID: 17063465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers.
    Blumrich A; Zapatka M; Brueckner LM; Zheglo D; Schwab M; Savelyeva L
    Hum Mol Genet; 2011 Apr; 20(8):1488-501. PubMed ID: 21258086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD).
    Hormozian F; Schmitt JG; Sagulenko E; Schwab M; Savelyeva L
    Cancer Lett; 2007 Feb; 246(1-2):82-91. PubMed ID: 16556484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
    Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
    Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
    Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
    Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-random inactivation of large common fragile site genes in different cancers.
    McAvoy S; Ganapathiraju SC; Ducharme-Smith AL; Pritchett JR; Kosari F; Perez DS; Zhu Y; James CD; Smith DI
    Cytogenet Genome Res; 2007; 118(2-4):260-9. PubMed ID: 18000379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.
    Pelliccia F; Bosco N; Rocchi A
    Cancer Lett; 2010 Dec; 299(1):37-44. PubMed ID: 20851513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicolor FISH mapping of YAC clones in 3p14 and identification of a YAC spanning both FRA3B and the t(3;8) associated with hereditary renal cell carcinoma.
    Wilke CM; Guo SW; Hall BK; Boldog F; Gemmill RM; Chandrasekharappa SC; Barcroft CL; Drabkin HA; Glover TW
    Genomics; 1994 Jul; 22(2):319-26. PubMed ID: 7806217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites.
    Huang H; Qian J; Proffit J; Wilber K; Jenkins R; Smith DI
    Oncogene; 1998 May; 16(18):2311-9. PubMed ID: 9620548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene.
    SawiƄska M; Schmitt JG; Sagulenko E; Westermann F; Schwab M; Savelyeva L
    Genes Chromosomes Cancer; 2007 Nov; 46(11):991-9. PubMed ID: 17668870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that instability within the FRA3B region extends four megabases.
    Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI
    Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1--relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints.
    Helmrich A; Stout-Weider K; Matthaei A; Hermann K; Heiden T; Schrock E
    Int J Cancer; 2007 Jan; 120(1):48-54. PubMed ID: 17039484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.